PNP Therapeutics, UAB and Southern Research Institute work abolishes otherwise unmanageable human cancers in preclinical rodent studies.

Biomarkers could tailor preventative or therapeutic aspirin regimens by predicting colorectal cancer patients’ response.
UAB cancer expert provides the deeper understanding on summer skin protection from UV rays, offers helpful tips.
Published in News You Can Use

“Complementary and Alternative Therapies: What You (And Your Doctor) Don’t Know Can Hurt You” to be held Jan. 24

Published in Service to Community
New clinic provides high-quality care with infusion therapy to Bessemer and Tuscaloosa-area communities.
Published in Focus on Patient Care
NEJM study shows aspirin has the potential to block tumor growth in certain colorectal cancer patients.
Published in Focus on Patient Care

Friedman will conduct research on medulloblastoma, the most common malignant brain tumor found in children.

Harry P. Erba, M.D., Ph.D., the inaugural holder of the Albert F. LoBuglio Endowed Chair for Translational Cancer Research
Published in Faculty Excellence

New director to help establish UAB as the South’s leading center for treating leukemia, lymphoma, multiple myeloma and related diseases.

Published in Focus on Patient Care
JAMA study shows advances, but editorial by UAB faculty says more long-term study is needed.
Published in Focus on Patient Care

Cancer researcher lauded for his work in cancer therapeutics.

Published in Faculty Excellence

UAB faculty will give 25 presentations at ASCO scientific meeting; topics also include ovarian and breast cancers and AML, or acute myeloid leukemia.

Published in Focus on Patient Care

Forero-Torres will be the first holder of a professorship position endowed by the O'Neal-Sokol Breast Cancer Research Foundation of Alabama.

Published in Faculty Excellence

Laboratory evidence offers new insight in blocking cancer cell growth with electromagnetic fields.

Six UAB teams are finalists in the 2011-12 Alabama Launchpad class.

The therapy uses very low electromagnetic frequencies without medications or chemotherapy and showed significant results in a phase II study.
Published in Focus on Patient Care

A drug long used for adults with sickle cell disease could change how the disease is managed in very young children.

Page 2 of 3
Back to Top